These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 8311114)
1. c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung. Li ZH; Zheng J; Weiss LM; Shibata D Am J Pathol; 1994 Feb; 144(2):303-9. PubMed ID: 8311114 [TBL] [Abstract][Full Text] [Related]
2. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572 [TBL] [Abstract][Full Text] [Related]
3. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632 [TBL] [Abstract][Full Text] [Related]
4. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma. Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277 [TBL] [Abstract][Full Text] [Related]
5. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer. Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767 [TBL] [Abstract][Full Text] [Related]
6. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992 [TBL] [Abstract][Full Text] [Related]
7. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Hongyo T; Buzard GS; Palli D; Weghorst CM; Amorosi A; Galli M; Caporaso NE; Fraumeni JF; Rice JM Cancer Res; 1995 Jun; 55(12):2665-72. PubMed ID: 7780983 [TBL] [Abstract][Full Text] [Related]
8. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602 [TBL] [Abstract][Full Text] [Related]
9. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features. Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473 [TBL] [Abstract][Full Text] [Related]
10. Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT. Hong HH; Dunnick J; Herbert R; Devereux TR; Kim Y; Sills RC Environ Mol Mutagen; 2007; 48(3-4):299-306. PubMed ID: 16395694 [TBL] [Abstract][Full Text] [Related]
11. C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. Kern JA; Slebos RJ; Top B; Rodenhuis S; Lager D; Robinson RA; Weiner D; Schwartz DA J Clin Invest; 1994 Feb; 93(2):516-20. PubMed ID: 7906694 [TBL] [Abstract][Full Text] [Related]
12. [Detection of K-ras mutation from malignant cells in sputum with mutant-allele specific amplification (MASA) method]. Kimura S; Fukuchi K; Takeda S; Shin S; Saito D; Akamatsu S; Himeji Y; Chen GL; Watanabe H; Takagi Y Rinsho Byori; 1995 Jul; 43(7):718-23. PubMed ID: 7674546 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation. Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567 [TBL] [Abstract][Full Text] [Related]
14. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Sugio K; Ishida T; Yokoyama H; Inoue T; Sugimachi K; Sasazuki T Cancer Res; 1992 May; 52(10):2903-6. PubMed ID: 1581907 [TBL] [Abstract][Full Text] [Related]